Véronique Gelsi‐Boyer

Mutations of polycomb‐associated gene <i>ASXL1</i> in myelodysplastic syndromes and chronic myelomonocytic leukaemia

Véronique Gelsi‐Boyer, Virginie Trouplin, José Adélaı̈de et al. · British Journal of Haematology · 2009 · 556 citations · Full text

Life Sciences, Hematology, Molecular Genetics +17

Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia

Raphaël Itzykson, Olivier Kosmider, Aline Renneville et al. · Journal of Clinical Oncology · 2013 · 545 citations

Medicine, Genetics, Oncology +17

Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias

Raphaël Itzykson, Olivier Kosmider, Thomas Cluzeau et al. · Leukemia · 2011 · 465 citations

Medicine, Molecular Genetics, Oncology +16

TET2 mutation is an independent favorable prognostic factor in myelodysplastic syndromes (MDSs)

Olivier Kosmider, Véronique Gelsi‐Boyer, Meyling Cheok et al. · Blood · 2009 · 270 citations

Life Sciences, Genetics, Molecular Genetics +11

Comprehensive Profiling of 8p11-12 Amplification in Breast Cancer

Véronique Gelsi‐Boyer, Béatrice Orsetti, Nathalie Cervera et al. · Molecular Cancer Research · 2005 · 242 citations · Full text

Medicine, Genetics, Oncology +16